Healthcare Global Enterprises Limited (HCG)
ISIN: INE075I01017 Industry: Medical Care Facilities Sector: Healthcare Website
283.8
0.65(0.23%)

HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates four multi-specialty hospitals, including three under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat, as well as one under operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. As of March 31, 2021, it operated 23 cancer centers, including 1 center of excellence in Bengaluru, 2 freestanding diagnostic centers, and 1 day care chemotherapy center across India, as well as 1 cancer center in Africa. The company was founded in 1989 and is based in Bengaluru, India.

Pricing Updates

TODAY'S HIGH

287.05

TODAY'S LOW

281.35

52 WEEK HIGH

308.8

52 WEEK LOW

212.5

Major Holders

% of Shares Held by
All Insider

73.86%

% of Shares Held by
Institutions

8.25%

% of Float Held by
Institutions

31.56%

Number of Institutions
Holding Shares

9

Company Overview

MARKET CAP

3945.27 Cr.

ETERPRISE VALUE

4618.64 Cr.

NO. OF SHARES

13.90 Cr.

BOOK VALUE

62.475

DIV. YIELD

None%

DEBT

914.66 Cr.

GROSS PROFIT

513.42 Cr.

CASH

231.64 Cr.

REVENUE

1482.69 Cr.

REVENUE/SHARE

111.752

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments155.41 Cr.-288.36 Cr.3.50 Cr.-5.68 Cr.
Change To Liabilities44.30 Cr.52.89 Cr.18.18 Cr.46.17 Cr.
Total cashflows from Investing Activities124.58 Cr.-171.10 Cr.-101.38 Cr.-238.19 Cr.
Net Borrowings-191.36 Cr.-205.98 Cr.23.12 Cr.129.53 Cr.
Total Cash from Financing Activities-154.88 Cr.112.24 Cr.-58.42 Cr.83.51 Cr.
Other Liabilities-8.30 Cr.7.87 Cr.-11.76 Cr.-8.56 Cr.
Total Assets132.16 Cr.452.61 Cr.20.32 Cr.9.30 Lakhs
Net Income53.73 Cr.-193.46 Cr.-106.69 Cr.-24.79 Cr.
Change in Cash189.82 Cr.61.65 Cr.-29.67 Cr.-56.18 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities220.12 Cr.120.52 Cr.130.13 Cr.98.50 Cr.
Depreciation158.28 Cr.147.18 Cr.142.31 Cr.81.84 Cr.
Other Cashflows from Investing Activities157.04 Cr.159.02 Cr.2.50 Cr.-11.66 Cr.
Dividends Paid0000
Change to Inventory-6.08 Cr.2.15 Cr.3.51 Cr.-2.74 Cr.
Change to Account Receivables-40.44 Cr.-7.84 Cr.-32.58 Cr.-32.75 Cr.
Other Cashflows from Financing Activities-95.68 Cr.-134.39 Cr.-101.87 Cr.-46.11 Cr.
Change to Net Income18.63 Cr.99.69 Cr.111.03 Cr.36.11 Cr.
Capital Expenditures-71.23 Cr.-35.42 Cr.-107.81 Cr.-188.78 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax87.77 Cr.-228.66 Cr.-119.26 Cr.-33.37 Cr.
Minority Interest13.43 Cr.16.82 Cr.38.51 Cr.45.54 Cr.
Net Income79.70 Cr.-33.37 Cr.22.94 Cr.39.60 Cr.
Selling General Administrative018.95 Cr.26.37 Cr.68.51 Cr.
Gross Profit513.42 Cr.527.39 Cr.612.05 Cr.574.93 Cr.
Ebit79.70 Cr.-33.37 Cr.22.94 Cr.39.60 Cr.
Operating Income79.70 Cr.-33.37 Cr.22.94 Cr.39.60 Cr.
Other Operating Expenses275.44 Cr.382.59 Cr.411.74 Cr.381.72 Cr.
Interest Expense-97.77 Cr.-113.66 Cr.-123.45 Cr.-50.48 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense48.85 Cr.-7.56 Cr.6.18 Cr.-2.50 Cr.
Total Revenue1397.79 Cr.1013.43 Cr.1095.63 Cr.978.67 Cr.
Total Operating Expenses1318.09 Cr.1046.80 Cr.1072.69 Cr.939.06 Cr.
Cost of Revenue884.37 Cr.486.03 Cr.483.58 Cr.403.74 Cr.
Total Other Income Expense Net8.07 Cr.-195.28 Cr.-142.21 Cr.-72.98 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.38.92 Cr.-221.10 Cr.-125.45 Cr.-30.87 Cr.
Net Income Applicable to Common Shares53.73 Cr.-193.46 Cr.-106.69 Cr.-24.79 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets29.80 Cr.21.48 Cr.32 Cr.9.33 Cr.
Capital Surplus0997.45 Cr.579.62 Cr.558.73 Cr.
Total Liabilities1335.81 Cr.1321.61 Cr.1833.40 Cr.1131.35 Cr.
Stock Holder Equity870.29 Cr.697.17 Cr.381.25 Cr.476.64 Cr.
Minority Interest13.43 Cr.16.82 Cr.38.51 Cr.45.54 Cr.
Other Liabilities172.62 Cr.142.65 Cr.236.11 Cr.275.02 Cr.
Total Assets2219.53 Cr.2035.61 Cr.2253.17 Cr.1653.54 Cr.
Common Stock139.01 Cr.125.35 Cr.88.69 Cr.87.91 Cr.
Retained Earnings0-475.10 Cr.-292.22 Cr.-173.21 Cr.
Other Liabilities37.29 Cr.40.88 Cr.118.87 Cr.67.12 Cr.
Good Will181.27 Cr.96.34 Cr.109.34 Cr.109.34 Cr.
Treasury Stock731.28 Cr.49.46 Cr.5.16 Cr.3.20 Cr.
Other Assets139.50 Cr.149.95 Cr.206.60 Cr.189 Cr.
Cash197.51 Cr.30 Cr.31.74 Cr.20.51 Cr.
Current Liabilities469.75 Cr.465.24 Cr.575.74 Cr.547.31 Cr.
Long Term Asset Charges5.95 Cr.34.31 Cr.26.14 Cr.26.86 Cr.
Short Long Term Debt44.76 Cr.32.96 Cr.24.03 Cr.26.63 Cr.
Other Stockholder Equity731.28 Cr.49.46 Cr.5.16 Cr.3.20 Cr.
Property Plant Equipment1357.80 Cr.1294.56 Cr.1550.82 Cr.1004.17 Cr.
Total Cur. Assets502.35 Cr.434.96 Cr.303.78 Cr.272.96 Cr.
Long Term Investments8.81 Cr.38.30 Cr.50.61 Cr.68.73 Cr.
Net Tangible Assets659.22 Cr.579.35 Cr.239.90 Cr.357.97 Cr.
Short Term Investments34.13 Cr.135.73 Cr.10.49 Cr.6.61 Cr.
Net Receivables219.06 Cr.214.79 Cr.208.06 Cr.188.74 Cr.
Long Term Debt362.87 Cr.346.17 Cr.529.61 Cr.460.53 Cr.
Inventory29.97 Cr.21.10 Cr.23.25 Cr.26.77 Cr.
Accounts Payable193.95 Cr.145.51 Cr.153.57 Cr.152.74 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account